Search for: "Glaxo Group Limited "
Results 1 - 20
of 43
Sorted by Relevance
|
Sort by Date
3 Feb 2011, 9:34 am
In reasons issued late last year, the Federal Court of Appeal has upheld a decision to expunge a trademark registration obtained by Glaxo Group Limited (“Glaxo”) for two-tones of the colour purple as applied to the visible surface of an asthma inhaler. [read post]
29 Oct 2007, 7:55 am
Apparently the government's lawyers had a long weekend, because on Sunday, the USPTO filed its opposition to Glaxo's motion for preliminary injunction against the new claim and continuation limit rules. [read post]
7 May 2017, 11:00 pm
In May 2016, Glaxo applied to join Sandoz International, Aeropharm and Hexel as defendants (all proposed defendants are within the Sandoz group). [read post]
21 Mar 2009, 6:07 am
Cir. 2009, 08-1352) Triantafyllos Tafas, SmithKline Beecham Corporation, and Glaxo Group Limited (collectively “Appellees”) originally filed suit against the USPTO in relation to Final Rules published by the USPTO that placed [...] [read post]
5 Mar 2021, 6:00 am
GLAXO GROUP LIMITED and HUMAN GENOME SCIENCES, INC. v. [read post]
8 Oct 2009, 1:56 pm
PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. [read post]
19 Nov 2020, 3:18 pm
GSK lost its appeal at the CAFC: Following trial, a jury in the United States District Court for the District of Delaware found that defendants GlaxoSmithKline LLC and Glaxo Group Limited (collectively, “GSK”) infringed U.S. [read post]
9 May 2013, 3:31 am
(Glaxo). [read post]
23 Jan 2013, 12:32 pm
”); Glaxo Group Ltd. v. [read post]
5 May 2009, 5:57 am
The Supreme Court ruling "significantly limited preemption. [read post]
11 Aug 2010, 6:14 am
” Glaxo Group, 153 F.3d at 1373. [read post]
9 Oct 2009, 11:50 am
In his remarks before thousands of employees on the USPTO campus, Secretary Locke said "David is taking on a big job… Promoting and protecting U.S. [...]...USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007… [read post]
19 Oct 2009, 5:53 pm
It is impossible not to recognize the new [...]...USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group… [read post]
13 Nov 2009, 11:52 am
USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO's motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. [read post]
13 Nov 2015, 8:02 am
Patent No. 6,284,770) was originally owned by Glaxo as was the primary prior art reference (U.S. [read post]
17 Oct 2006, 2:04 pm
Glaxo Wellcome, the Spanish subsidiary of the GlaxoSmithKline group, adopted new General Sales Conditions in 1998, which stipulated that its medicines will be sold to Spanish wholesalers at prices differentiated according to the national sickness insurance scheme which will reimburse them. [read post]
25 Nov 2009, 12:00 pm
US: Federal Circuit to hear oral argument in Ajinomoto v ITC 10 December (ITC Law Blog) US: Athena Diagnostics files suits against Ambry Genetics over alleged infringement of patents covering diagnostic technologies (Patent Docs) Products Dovonex (Calcipotriol) – UK: EWCA (Civ): Follow the instruction or lose the case - Sandoz's attempts at having finding of lack of anticipation overturned fails, appeal dismissed: Leo v Sandoz (IPKat) Famvir (Famciclovir) – US: New Jersey… [read post]
17 Apr 2012, 8:21 am
Glaxo says the sales force clearly is exempt under current law. [read post]
21 Sep 2010, 7:47 pm
(FDA Law Blog) US: FDA set to announce public hearing on BPCI Act implementation (FDA Law Blog) US: Precision Biosciences granted stay pending reexam of Cellectis’ patents (Patent Docs) US: Celsis granted preliminary injunction against CellzDirect in LiverPool hepatocyte treatment infringement suit (Patent Docs) US: Yeda Research and Development files suit against Abbott in District of Columbia requesting review of BPAI decision (Patent Docs) Products Angiomax (Bivalirudin) – US: The… [read post]
13 Sep 2009, 12:55 am
Shapira) indicating that court orders can override confidential information, even for financial records, and Glaxo-Wellcome PLC v. [read post]
